Edit

Altos Labs

https://altoslabs.com/
Last activity: 11.09.2026
Active
Categories: BioTechHealthTechIndustryLifeScience
Altos Labs is a new life science company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine.
Mentions
25

Investors 3

Mentions in press and media 25

DateTitleDescription
11.09.2026Luma перестроила модель венчурного фонда под разработку лекарствИнвестиционная компания Luma Group завершила формирование своего первого венчурного фонда LumaBio I объемом $410 млн для вложений в биотехнологии и другие проекты в сфере наук о жизни. От обычных венчурных фондов он отличается сроком работы...
07.09.2026Thore Graepel Leaves DeepMind: AlphaGo Co-Creator Bets Structured Search Over LLM ScalingBy Collin Mercer Published: Sep 07 2026, 3:08 PM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard
30.06.2026Verge Labs представила «виртуальную биопсию» для разработки лекарств от болезней мозгаСоздание лекарств от заболеваний мозга остается одной из самых сложных и рискованных задач в медицине. Компания Verge Labs пытается ускорить этот процесс с помощью искусственного интеллекта, который анализирует данные о человеческом мозге и...
01.01.2026Lemon Slice Raises $10.5M in Seed FundingLemon Slice, a San Francisco, CA-based builder of foundational technology that transforms a single photo into interactive, conversational video, raised $10.5m in seed funding. Backers included Matrix Partners, Y Combinator, Arash Ferdowsi (...
01.01.2026The Longevity Startup That Already Has the Data Altos Labs Is Seeking: Hidden in Plain SightWhile Jeff Bezos and Sam Altman fund billion-dollar moonshots in cellular rejuvenation, one biotechnology company has been quietly treating patients for seven years, accumulating the kind of clinical data that typically takes a decade and h...
20.12.2025Is AI implementation being rushed to expand billionaires’ lifespans? (Opinion)Getting your Trinity Audio player ready... By Ron Sandgrund Since humankind’s earliest days, many have feared dying and sought immortality. The billionaire technologists driving our AI research and implementation certainly are not immune to...
22.07.2025Latent Labs aims to replace trial-and-error drug discovery with push-button designToday Latent Labs launches Latent-X, a frontier AI model for push button protein design, which outperforms competing models under identical laboratory conditions. Latent Labs is working to transform the expensive, labour-intensive, and high...
20.05.2025Sam Altman-Backed Startup Aims to Add 10 Years to Human Life Through Stem Cell TechOpenAI’s Sam Altman has poured millions into the longevity-focused Retro Biosciences. Sean Gallup/Getty Images The average American can expect to live about 77 years, according to the Centers for Disease Control and Prevention. Retro Biosci...
13.02.2025Latent Labs: The New Frontier in Programmable BiologyIn the world of biotechnology, a new player has emerged, ready to rewrite the rules. Latent Labs, a London-based startup, has burst onto the scene with a staggering $50 million in funding. This infusion of capital is not just a number; it’s...
13.02.2025AI pioneer Dr Simon Kohl's Latent Labs emerges from stealth, raising $50M for programmable biologyAI foundation model builder Latent Labs today emerged from stealth with $50 million in total funding to accelerate their progress in programmable biology. The company was founded by Dr Simon Kohl, previously a co-lead of DeepMind’s protein ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In